Thomas D. Aicher
53Patents
8h-index
92Co-inventors
77Inventor score
Filing activity: Mar 17, 2003 → Mar 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7449486B2 | Mitotic kinesin inhibitors and methods of use thereof | Chemistry; Metallurgy | 22 | Expired |
| US9266827B2 | Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease | Chemistry; Metallurgy | 22 | Active |
| US9512111B2 | N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease | Chemistry; Metallurgy | 21 | Active |
| US9657033B2 | Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease | Chemistry; Metallurgy | 19 | Active |
| US9394315B2 | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Chemistry; Metallurgy | 14 | Active |
| US9663502B2 | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease | Chemistry; Metallurgy | 12 | Active |
| US9783511B2 | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 9 | Active |
| US7214673B2 | Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders | Chemistry; Metallurgy | 8 | Expired |
| US9809561B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 8 | Active |
| US7956073B2 | Mitotic kinesin inhibitors and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US9802958B2 | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease | Chemistry; Metallurgy | 7 | Active |
| US9896441B2 | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Chemistry; Metallurgy | 6 | Active |
| US7384934B2 | Piperazine substituted aryl benzodiazepines | Chemistry; Metallurgy | 6 | Expired |
| US10221146B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 6 | Active |
| US8236825B2 | Mitotic kinesin inhibitors and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10208061B2 | Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Chemistry; Metallurgy | 6 | Active |
| US10377768B2 | Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Chemistry; Metallurgy | 5 | Active |
| US8623895B2 | Mitotic kinesin inhibitors and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US8022222B2 | Glucokinase activators | Chemistry; Metallurgy | 4 | Active |
| US9102639B2 | Mitotic kinesin inhibitors and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10189777B2 | Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease | Chemistry; Metallurgy | 2 | Active |
| US8022223B2 | 2-aminopyridine analogs as glucokinase activators | Chemistry; Metallurgy | 2 | Active |
| US10364237B2 | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Chemistry; Metallurgy | 2 | Active |
| US8362037B2 | 2-aminopyridine analogs as glucokinase activators | Chemistry; Metallurgy | 2 | Active |
| US10421751B2 | Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.